BMJ · 2006 · 442 citations · 23 references
MedicineInfectious Disease ControlPreventive MedicineDisease PreventionImmunizationVaccinologyAdult ImmunizationDisease ControlImmunization PracticeVaccinationVaccine EffectivenessVaccine EfficacyEfficacy Against InfectionInfluenza Infection ControlInfluenza-like Illness Rate EstimationOverall Vaccine EffectivenessPopulation-based Vaccine EffectivenessPrimary Outcome AnalysisVaccination Coverage AnalysisVaccination Coverage Assessment
OBJECTIVE: To determine whether vaccination of care home staff against influenza indirectly protects residents. DESIGN: Pair matched cluster randomised controlled trial. SETTING: Large private chain of UK care homes during the winters of 2003-4 and 2004-5. PARTICIPANTS: Nursing home staff (n=1703) and residents (n=2604) in 44 care homes (22 intervention homes and 22 matched control homes). INTERVENTIONS: Vaccination offered to staff in intervention homes but not in control homes. MAIN OUTCOME MEASURES: The primary outcome was all cause mortality of residents. Secondary outcomes were influenza-like illness and health service use in residents. RESULTS: In 2003-4 vaccine coverage in full time staff was 48.2% (407/884) in intervention homes and 5.9% (51/859) in control homes. In 2004-5 uptake rates were 43.2% (365/844) and 3.5% (28/800). National influenza rates were substantially below average in 2004-5. In the 2003-4 period of influenza activity significant decreases were found in mortality of residents in intervention homes compared with control homes (rate difference -5.0 per 100 residents, 95% confidence interval -7.0 to -2.0) and in influenza-like illness (P=0.004), consultations with general practitioners for influenza-like illness (P=0.008), and admissions to hospital with influenza-like illness (P=0.009). No significant differences were found in 2004-5 or during periods of no influenza activity in 2003-4. CONCLUSIONS: Vaccinating care home staff against influenza can prevent deaths, health service use, and influenza-like illness in residents during periods of moderate influenza activity. TRIAL REGISTRATION: National Research Register N0530147256.
23
Consort 2010 statement: extension to cluster randomised trials
Marion Campbell, Gilda Piaggio, Diana R Elbourne et al. · BMJ · 2012 · 3.6K citations · Full text
CONSORT statement: extension to cluster randomised trials
Marion Campbell, Diana R Elbourne, Douglas G. Altman · BMJ · 2004 · 2.6K citations · Full text
Competing interests: none declared.
L. Hirsch · 2006 · 1.4K citations